3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Prostatic Neoplasms
42
Lung Neoplasms
39
Leukemia, Myeloid, Acute
36
Carcinoma, Non-Small-Cell Lung
33
Neoplasm Metastasis
29
Breast Neoplasms
28
Myelodysplastic Syndromes
20
Lymphoma, Large B-Cell, Diffuse
20
Leukemia, Lymphocytic, Chronic, B-Cell
19
Colorectal Neoplasms
19
Pancreatic Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Multiple Myeloma
15
Triple Negative Breast Neoplasms
14
Ovarian Neoplasms
14
Glioblastoma
14
Carcinoma, Renal Cell
13
Burkitt Lymphoma
13
Squamous Cell Carcinoma of Head and Neck
12
Urinary Bladder Neoplasms
10
Melanoma
10
Lymphoma, Mantle-Cell
10
Endometrial Neoplasms
10
Carcinoma, Hepatocellular
10
Myeloproliferative Disorders
9
Mouth Neoplasms
9
Leukemia, Myelomonocytic, Chronic
9
Carcinoma
9
Brain Neoplasms
9
Oropharyngeal Neoplasms
8
Interventions
Tirzepatide
5
semaglutide
2
Tablets
2
Observation
2
Metformin
2
Exercise
2
Counseling
2
mirabegron
1
atezolizumab
1
Weights and Measures
1
Walk Test
1
Trehalase
1
Therapeutics
1
TIC10 compound
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Resistance Training
1
Progestins
1
Pregabalin
1
Population Groups
1
Omeprazole
1
Nutrition Assessment
1
Negative-Pressure Wound Therapy
1
Methods
1
Metabolic Networks and Pathways
1
Megestrol Acetate
1
Liraglutide
1
Letrozole
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Obesity
×
Specimen Handling
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled